NEW YORK (GenomeWeb) – Hologic reported after the close of the market on Wednesday that its third quarter revenues rose 12 percent year over year, crediting its molecular diagnostics and international businesses as drivers of new growth.

For the three months ended July 1, the firm reported total revenues of $806.1 million, up from $717.4 million in Q3 2016, and beating the average Wall Street analyst estimate of $799.7 million. On a constant-currency basis, revenues increased 13 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.